Post-ischemic Infusion of Atrial Natriuretic Peptide Attenuates Warm Ischemia-Reperfusion Injury in Rat Lung

Journal of Heart and Lung Transplantation

Volumn 28, Issue 6, 2009, Pages 628-634

  Aoyama, Akihiro ^a   Chen, Fengshi ^a   Fujinaga, Takuji ^a   Sato, Atsuyasu ^a   Tsuruyama, Tatsuaki ^b   Zhang, Jitian ^a   Shoji, Tsuyoshi ^a   Sakai, Hiroaki ^a   Nakamura, Takayuki ^a   Date, Hiroshi ^a   Wada, Hiromi ^a   Bando, Toru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; CYCLIC GMP; GUANYLATE CYCLASE; SINGLE STRANDED DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HISTOPATHOLOGY; ISOLATED LUNG; LUNG EDEMA; LUNG INJURY; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TISSUE OXYGENATION;

ANIMALS; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; CYCLIC AMP; LUNG; MALE; MODELS, ANIMAL; PERFUSION; RATS; RATS, INBRED LEW; REPERFUSION INJURY; WARM ISCHEMIA;

EID: 65749085676     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.03.015     Document Type: Article

References (48)

1. Egan T.M. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant 23 (2004) 3-10
2. Egan T.M., Lambert Jr. C.J., Reddick R., et al. A strategy to increase the donor pool: use of cadaver lungs for transplantation. Ann Thorac Surg 52 (1991) 1113-1120
3. Van Raemdonck D.E., Rega F.R., Neyrinck A.P., et al. Non-heart-beating donors. Semin Thorac Cardiovasc Surg 16 (2004) 309-321
4. Pinsky D.J., Naka Y., Chowdhury N.C., et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA 91 (1994) 12086-12090
5. Date H., Triantafillou A.N., Trulock E.P., et al. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 111 (1996) 913-919
6. Shiraishi Y., Lee J.R., Laks H., et al. L-arginine administration during reperfusion improves pulmonary function. Ann Thorac Surg 62 (1996) 1580-1586
7. Yamashita M., Schmid R.A., Ando K., et al. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg 62 (1996) 791-796
8. Schmid R.A., Hillinger S., Walter R., et al. The nitric oxide synthase cofactor tetrahydrobiopterin reduces allograft ischemia-reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 118 (1999) 726-732
9. Hillinger S., Schmid R.A., Sandera P., et al. 8-Br-cGMP is superior to prostaglandin E1 for lung preservation. Ann Thorac Surg 68 (1999) 1138-1142
10. Takashima S., Date H., Aoe M., et al. Short-term inhaled nitric oxide in canine lung transplantation from non-heart-beating donor. Ann Thorac Surg 70 (2000) 1679-1683
11. Kawashima M., Bando T., Nakamura T., et al. Cytoprotective effects of nitroglycerin in ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 161 (2000) 935-943
12. Egan T.M., Hoffmann S.C., Sevala M., et al. Nitroglycerin reperfusion reduces ischemia-reperfusion injury in non-heart-beating donor lungs. J Heart Lung Transplant 25 (2006) 110-119
13. Kuga H., Ogawa K., Oida A., et al. Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction. Circ J 67 (2003) 443-448
14. Wakui S. Experimental study on myocardial protection by adjunct use of carperitide (hANP) in cardiac surgery. Ann Thorac Cardiovasc Surg 11 (2005) 12-20
15. Okawa H., Horimoto H., Mieno S., et al. Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts. Mol Cell Biochem 248 (2003) 171-177
16. Kulhanek-Heinze S., Gerbes A.L., Gerwig T., et al. Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers. J Hepatol 41 (2004) 414-420
17. Gugenheim J. Atrial natriuretic peptide (ANP) preconditioning: what is the relevance of the antiapoptotic effects?. J Hepatol 39 (2003) 428-430
18. Kiemer A.K., Gerbes A.L., Bilzer M., et al. The atrial natriuretic peptide and cGMP: novel activators of the heat shock response in rat livers. Hepatology 35 (2002) 88-94
19. Kiemer A.K., Vollmar A.M., Bilzer M., et al. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J Hepatol 33 (2000) 236-246
20. Gerbes A.L., Vollmar A.M., Kiemer A.K., et al. The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver. Hepatology 28 (1998) 1309-1317
21. Neumayer H.H., Blossei N., Seherr-Thohs U., et al. Amelioration of postischaemic acute renal failure in conscious dogs by human atrial natriuretic peptide. Nephrol Dial Transplant 5 (1990) 32-38
22. Mitaka C., Hirata Y., Habuka K., et al. Atrial natriuretic peptide infusion improves ischemic renal failure after suprarenal abdominal aortic cross-clamping in dogs. Crit Care Med 31 (2003) 2205-2210
23. Imamura T., Ohnuma N., Iwasa F., et al. Protective effect of alpha-human atrial natriuretic polypeptide (alpha-hANP) on chemical-induced pulmonary edema. Life Sci 42 (1988) 403-414
24. Wakabayashi G., Ueda M., Aikawa N., et al. Release of ANP and its physiological role in pulmonary injury due to HCl. Am J Physiol 258 (1990) R690-R696
25. Lofton C.E., Baron D.A., Heffner J.E., et al. Atrial natriuretic peptide inhibits oxidant-induced increases in endothelial permeability. J Mol Cell Cardiol 23 (1991) 919-927
26. Irwin D.C., Rhodes J., Baker D.C., et al. Atrial natriuretic peptide blockade exacerbates high altitude pulmonary edema in endotoxin-primed rats. High Alt Med Biol 2 (2001) 349-360
27. Mitaka C., Hirata Y., Habuka K., et al. Atrial natriuretic peptide improves pulmonary gas exchange by reducing extravascular lung water in canine model with oleic acid-induced pulmonary edema. Crit Care Med 30 (2002) 1570-1575
28. Chen F., Nakamura T., Fujinaga T., et al. Protective effect of a nebulized beta2-adrenoreceptor agonist in warm ischemic-reperfused rat lungs. Ann Thorac Surg 82 (2006) 465-471
29. Fujinaga T., Nakamura T., Fukuse T., et al. Isoflurane inhalation after circulatory arrest protects against warm ischemia reperfusion injury of the lungs. Transplantation 82 (2006) 1168-1174
30. Kawashima M., Nakamura T., Schneider S., et al. Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance. J Heart Lung Transplant 22 (2003) 794-801
31. Nakamura T., Vollmar B., Menger M.D., et al. Heme oxygenase does not contribute to control of basal vascular tone in isolated blood-perfused rat lung. J Heart Lung Transplant 23 (2004) 599-605
32. Uhlig S., and Wollin L. An improved setup for the isolated perfused rat lung. J Pharmacol Toxicol Methods 31 (1994) 85-94
33. Lowry O.H., Rosebrough N.J., Farr A.L., et al. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
34. Kasagi S., Seyama K., Mori H., et al. Tomato juice prevents senescence-accelerated mouse P1 strain from developing emphysema induced by chronic exposure to tobacco smoke. Am J Physiol Lung Cell Mol Physiol 290 (2006) L396-L404
35. Van Raemdonck D.E., Jannis N.C., De Leyn P.R., et al. Warm ischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg 228 (1998) 788-796
36. Rega F.R., Jannis N.C., Verleden G.M., et al. Should we ventilate or cool the pulmonary graft inside the non-heart-beating donor?. J Heart Lung Transplant 22 (2003) 1226-1233
37. Steen S., Sjoberg T., Pierre L., et al. Transplantation of lungs from a non-heart-beating donor. Lancet 357 (2001) 825-829
38. Steen S., Sjoberg T., Ingemansson R., et al. Efficacy of topical cooling in lung preservation: is a reappraisal due?. Ann Thorac Surg 58 (1994) 1657-1663
39. Dodd-o J.M., Hristopoulos M.L., Kibler K., et al. The role of natriuretic peptide receptor-A signaling in unilateral lung ischemia-reperfusion injury in the intact mouse. Am J Physiol Lung Cell Mol Physiol 294 (2008) L714-L723
40. de Perrot M., Liu M., Waddell T.K., et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 (2003) 490-511
41. Gottlieb R.A., Burleson K.O., Kloner R.A., et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94 (1994) 1621-1628
42. Fischer S., Cassivi S.D., Xavier A.M., et al. Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg 231 (2000) 424-431
43. Gerwig T., Meissner H., Bilzer M., et al. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J Hepatol 39 (2003) 341-348
44. Van Putte B.P., Kesecioglu J., Hendriks J.M., et al. Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion. Crit Care 9 (2005) R1-R8
45. Sasaki H., Matsuno T., Tanaka N., et al. Activation of apoptosis during the reperfusion phase after rat liver ischemia. Transplant Proc 28 (1996) 1908-1909
46. Gao W., Bentley R.C., Madden J.F., et al. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 27 (1998) 1652-1660
47. Tang P.S., Mura M., Seth R., et al. Acute lung injury and cell death: how many ways can cells die?. Am J Physiol Lung Cell Mol Physiol 294 (2008) L632-L641
48. Uhlig S. The isolated perfused lung. In: Uhlig S., and Taylor A.E. (Eds). Methods in pulmonary research (1998), Birkhaeuser, Basel 29-55